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Assessment of Cytotoxicity Potency of Paclitaxel in Combination with Clinacanthus 
Nutans Extracts on Human MDA-MB-231 Breast Cancer Cells
(Penilaian Potensi Sitotoksisiti Paclitaxel secara Kombinasi dengan Ekstrak Clinacanthus Nutans terhadap 
Sel Kanser Payudara Manusia MDA-MB-231)
Nur HASNIEzA MOHD rOSlI, CHAN KOK MENg, FArIzA JulIANA NOrDIN, lEONg lEK MuN, Nur SyAzwANI ABDul AzIz & 
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ABSTrACT
Clinacanthus nutans (C. nutans) leaf extracts have been widely used by cancer patients in Malaysia and local practice 
claims a cure to cancer. There were several studies done to determine the cytotoxicity potency of C. nutans extracts on 
various types of cells. However, there is still lacking on the knowledge regarding the combination effect of C. nutans 
with anticancer drugs. Thus, the study was carried out to determine the cytotoxicity potency of C. nutans extracts and 
paclitaxel (PTX) alone and, in combination on MDA-MB-231 cells. The cells were treated with 100% ethanol extract of 
C. nutans (CNE) and water extract of C. nutans (CNA), PTX and combination of both extracts and PTX for 72 hours and 
the cytotoxic activity was determined using SRB assay. Result showed that CNE had little cytotoxic activity, whereas CNA 
showed no cytotoxic activity on MDA-MB-231 cells. For combination treatment of C. nutans extracts and PTX, only CNE 
showed significant enhanced PTX-induced cytotoxicity (p < 0.05), meanwhile CNA inhibited PTX-induced cytotoxicity 
significantly (p < 0.05). As a conclusion, CNE was able to increase PTX potency to inhibit the viability of MDA-MB-231 
cells.
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ABSTrAK
Ekstrak daun Clinacanthus nutans (C. nutans) telah digunakan secara meluas oleh pesakit kanser di Malaysia dan 
pengamal tempatan mendakwa ia dapat mengubati kanser. Beberapa kajian lepas telah dijalankan untuk menentukan 
potensi sitotoksisiti ekstrak C. nutans terhadap pelbagai jenis sel. Walau bagaimanapun, pengetahuan mengenai kesan 
kombinasi C. nutans dengan dadah antikanser adalah masih kurang. Oleh itu, kajian ini telah dijalankan untuk menentukan 
kesan potensi sitotoksisiti ekstrak C. nutans, paclitaxel (PTX) dan kombinasi di antara ekstrak C. nutans dengan PTX ke 
atas sel MDA-MB-231. Sel MDA-MB-231 telah dirawat dengan ekstrak 100% etanol C. nutans (CNE) dan esktrak air 
C. nutans (CNA), PTX dan kombinasi kedua-dua ekstrak dan PTX selama 72 jam dan aktiviti sitotoksik telah ditentukan 
menggunakan asai SRB. Hasil kajian menunjukkan CNE mempunyai aktiviti sitotoksik yang sedikit, manakala CNA tidak 
mempunyai aktiviti sitotoksik. Bagi rawatan kombinasi ekstrak C. nutans dan PTX, kombinasi CNE dan PTX menunjukkan 
peningkatan kesan sitotoksik secara signifikan (p < 0.05). Kesimpulannya, CNE berkebolehan untuk meningkatkan potensi 
PTX untuk merencat viabiliti sel MDA-MB-231.
Kata kunci: Clinacanthus nutans; paclitaxel; sel MDA-MB-231; aktiviti sitotoksisiti
INTrODuCTION
Breast cancer is the commonest cancer among women 
(Omar & Tamim 2011). It is estimated that age-standardized 
rate (ASr) for breast cancer in Malaysia was 38.7 per 
100000 with 5410 new cases in 2012, according to IArC 
(glOBOCAN) in 2012 (IArC 2016). Breast cancers are 
heterogenous in nature consisting of a few major subtypes 
including luminal A, luminal B, human epidermal growth 
factor receptor (HEr-2) positive and basal cell-like (BCl) 
or triple negative breast cancer (TNBC) (griffiths & Olin 
2012; Schnitt 2010; Spitale et al. 2009).
Current chemotherapeutic approach includes specific 
antihormonal therapies that are ready for use against the 
hormonal receptors such as estrogen receptor (Er) and 
progesterone receptor (Pr) along with human HEr-2 
(griffiths & Olin 2012). For metastatic HEr-2 positive 
cancer patients, trastuzumab is suggested as first-line 
treatment which can be administered as a single agent or 
in combination with endocrine treatment or chemotherapy, 
including in adjuvant setting (Awada et al. 2012). For TNBC, 
the only choice of treatment for TNBC is conventional 
systemic cytotoxic chemotherapy such as taxanes and 
anthracyclines. Furthermore, TNBC is characterized as 
higher aggressive behavior, earlier relapses, different 
patterns or metastases and greater rates of mortality 
compared to other breast tumors, thus very potent treatment 
is required (Elias 2010; griffiths & Olin 2012).
PTX, a class of taxane drugs is a natural diterpenoid 
pseudoalkaloid that target microtubules. It interrupts the 
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231 cells were cultured in DMEM, supplemented with 10% 
FBS, sodium pyruvate (100 mM) and antibiotic-antimycotic 
(100x). MDA-MB-231 cells were cultured in T75 cm2 flask 
in a humidified atmosphere containing 5% CO2 incubator 
at 37°C. Further maintenance and subculturing of cells 
were performed according to ATCC guideline. 
ETHANOl AND wATEr EXTrACTS OF CLINACANTHUS 
NUTNAS (C. NUTANS)
100% ethanol extract of C. nutans (CNE) and water extract 
of C. nutans (CNA) leaves crude extracts were obtained 
from universiti Putra Malaysia (uPM). Prior to use, both 
extracts were dissolved in 100% DMSO.
CyTOTOXICITy ASSAy
Sulforhodamine B (SrB) assay was performed to determine 
the cytotoxic activity of the C. nutans extracts, PTX and 
combination of both on MDA-MB-231 cells. SrB assay 
was performed as previously described (Houghton et al. 
2007). Briefly, 5 × 104 cells/ml MDA-MB-231 cells were 
seeded into 96-well plates and allowed to growth overnight. 
On the next day, the cells were exposed to serial dilutions 
of PTX, C. nutans extracts, or combination of C. nutans 
extracts and IC50 of PTX for 72 hours. After 72 hours, 50 
µl of 50% w/v tricholoroacetic acid was added to the wells 
and incubated at 4°C for 1 hour. Then, the plates were 
washed for five times with distilled water and allowed to 
dry in the air. 50 µl of 0.4% SrB dye solution were added 
into each well of the dry 96-well plate and allowed staining 
at room temperature for 30 minutes. After that, the SrB 
solution was removed by washing the plates quickly with 
1% acetic acid for five times to remove the unbound dye. 
The washed plates were dried in the air. The bound SrB 
was solubilized by adding 100 µl of 10 mM unbuffered Tris 
base (pH 10.5) into each well and the plates were shaken 
for 5 minutes on the microplate shaker. The absorbance 
of each well was measured by using an ElISA microplate 
reader at 570 nm. The viability of the cells was calculated 
by using the following formula:
 Percentage of Cell = OD Treated Cell × 100%
 Viability  OD untreated Cell
STATISTICAl ANAlySIS
All experiments were carried out in triplicates and results 
were expressed as mean ± standard error mean (SEM). One-
way ANOVA was used to compare between the control group 
and the groups treated with PTX alone, C. nutans extracts 
alone and combination of PTX and C. nutans extracts on cell 
viability. A p-value of < 0.05 was considered statistically 
significant.
cell cycle in the g0/g1 and g2/M phase which can lead 
the cells undergo apoptosis (zhang et al. 2014; Kampan 
et al. 2015). For breast cancer, it is used as a first-line 
treatment and it can be administered as a single agent, 
but it is commonly administered in combination with 
an anthracycline such as doxorubicin since it improves 
disease-free survival and overall survival (Sprouse et al. 
2014). PTX has lots of serious side effects and great level 
of toxicity like majority of chemotherapy drugs (liu et 
al. 2013). The side effects and toxicity of PTX at higher 
doses are neutropenia and neuropathy. Therefore, these 
significantly restrict dosage of PTX and its use in patients 
(Sprouse 2014; liu et al. 2013).
Clinacanthus nutans (C. nutans) is a plant belongs to 
Acanthaceae family (wanikiat et al. 2008). It is commonly 
known as Belalai gajah, Sabah Snake grass in Malaysia, 
phaya yo or phaya plongtong in Thailand and giro de 
flores, cocodrilo flor, e zui hua in Chinese dialect. It has 
been utilized as conventional medicine in Thailand and 
Malaysia. In Thailand, fresh leaves alcoholic extract is 
applied externally for treatment of skin rashes, herpes 
simplex and varicella-zoster virus lesions (Aslam et al. 
2014). It is a popular medicinal plants extensively used in 
Thai conventional medicine and are classified as important 
medicinal plants for basic healthcare by the Thai Ministry 
of Public Health (wanikiat et al. 2008). In Malaysia, the 
raw leaves are boiled with water and drank as herbal tea 
(Aslam et al. 2014). It is used for treatment of diabetes 
mellitus, fever, diarrhea, dysuria, skin rashes and snake 
bites and wounds due to herpes simplex virus (Aslam et 
al. 2014; P’ng et al. 2012).
Previous study has shown that C. nutans possessed 
antiproliferative activities against cancer cell lines (yong 
et al. 2013). This suggested that C. nutans has the potential 
to be used as an alternative adjuvant or neoadjuvant 
chemotherapy treatment for cancer or can be consumed for 
cancer prevention. Currently, combination therapy is more 
favourable due to its likelihood to reduce development of 
resistant cancer cells and its ability to reduce the adverse 
effects of the drugs. However, there is no study on the 
combination effect of C. nutans with anticancer drugs to 
date. In the present study, MDA-MB-231 human breast 
cancer cells, a triple negative subtype that has aggressive 
behavior was used. These cells are treated with PTX in 
combination with C. nutans extracts to assess the cytotoxic 
potency of the combination treatment against the breast 
cancer cells. This study may lead to the discovery of a 
new combination chemotherapy regime that can be used 
for the treatment of breast cancer in addition to the existing 
treatments currently available.
MATErIAlS AND METHODS
CEllS AND CEll CulTurE
MDA-MB-231 human breast cancer cell line was purchased 
from American Type’s Tissue Culture (ATCC). MDA-MB-
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rESulTS
THE CyTOTOXIC ACTIVITy OF PTX ON MDA-MB-231 CEllS
Determination of IC50 was done using graphs generated 
from Microsoft Excel 2007 edition. The effect of PTX 
on MDA-MB-231 cells viability was investigated to 
determine the IC50. The cells were cultured in the presence 
of increasing concentrations of PTX (0-0.05 µg/ml) for 72 
hours and the cellular viability was evaluated using SrB 
assay. At 0.05 µg/ml, PTX significantly reduced the MDA-
MB-231 cellular viability to 47.19 ± 1.73% (p < 0.05). The 
IC50 value obtained was 0.028 µg/ml. The percentage of 
viability is shown in Figure 1.
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FIgurE 1. The mean of percentage of MDA-MB-231 cells viability versus the concentration of PTX treated for 72 hours. Every point 
represents mean ± SEM for triplicate from three different experiments (n = 3). *p < 0.05 compared to negative control.  
FIgurE 2. The mean of percentage of MDA-MB-231 cells viability versus the concentration of CNE treated for 72 hours. Every 
point represents mean ± SEM for triplicate from three different experiments (n = 3). *p < 0.05 compared to negative control.
THE CyTOTOXIC ACTIVITy OF C. NUTANS EXTrACTS ON 
MDA-MB-231 CEllS
The effect of CNE and CNA on MDA-MB-231 cells viability 
was investigated. The cells were cultured in the presence 
of increasing concentrations of CNE (0-0.5 mg/ml) for 72 
hours and the cellular viability was evaluated using SrB 
assay. At 0.5 mg/ml, the CNE significantly reduced the 
MDA-MB-231 cellular viability to 67.70 ± 3.21% (p < 
0.05). The percentage of viability is shown in Figure 2.
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The cells were also cultured in the presence of 
increasing concentrations of CNA (0-1 mg/ml) for 72 hours 
and the cellular viability was evaluated using SrB assay. 
At 1 mg/ml, the CNA slightly reduced the MDA-MB-231 
cellular viability to 97.35 ± 0.71%. The percentage of 
viability is shown in Figure 3.
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FIgurE 3. The mean of percentage of MDA-MB-231 cells viability versus the concentration of CNA treated for 72 hours. Every 
point represents mean ± SEM for triplicate from three different experiments (n = 3). *p < 0.05 compared to negative control.
THE CyTOTOXIC ACTIVITy OF C. NUTANS EXTrACTS IN 
COMBINATION wITH PTX ON MDA-MB-231 CEllS
The MDA-MB-231 cells were cultured in the presence 
of increasing concentrations of CNE (0.125-0.5 mg/ml) in 
combination with IC50 of PTX (0.028 µg/ml) for 72 hours 
and the cellular viability was evaluated by using SrB assay. 
The mean of cell viability for the MDA-MB-231 cells 
decreased from 82.61 ± 7.05% to 69.30 ± 4.15% with 
increasing doses of CNE (0.125-0.5 mg/ml) alone. The mean 
of cell viability for the MDA-MB-231 cells increased from 
31.05 ± 1.87% to 34.02 ± 0.59% for the combination with 
CNE (0.125-0.5 mg/ml) and PTX (0.028 µg/ml). The mean 
of cell viability for PTX (0.028 µg/ml) alone was 45.33 
± 5.42%. The combination of all concentrations of CNE 
and PTX had significantly lower percentage of viability 
compared to PTX alone (p < 0.05). Significant decreased 
of cell viability at all concentrations of CNE in combination 
with PTX was also observed compared to CNE (p < 0.05). 
The percentage of cell viability is shown in Figure 4.
The MDA-MB-231 cells were cultured in the presence 
of increasing concentrations of CNA (0.5-1 mg/ml) 
combined with IC50 of PTX (0.028 µg/ml) for 72 hours and 
the cellular viability was evaluated by using SrB assay. The 
mean of cell viability for the MDA-MB-231 cells decreased 
from 81.97 ± 2.64% to 74.45 ± 1.22% with increasing doses 
of CNA (0.5-1 mg/ml) alone. The mean of cell viability for 
the MDA-MB-231 cells increased from 46.58 ± 1.34% to 
53.06 ± 1.73% for the combination with CNA (0.5-1 mg/
ml) and PTX (0.028 µg/ml). The mean of cell viability for 
PTX (0.028 µg/ml) alone was 41.61 ± 0.78%. Significant 
increased of cell viability of concentration 1 mg/ml of 
CNA in combination with PTX was observed compared to 
PTX alone (p < 0.05). However, significant decreased of 
cell viability of all concentrations of CNA in combination 
with PTX was observed compared to C. nutans extract 
alone (p < 0.05). The percentage of cell viability is shown 
in Figure 5.
MOrPHOlOgICAl CHANgES ON MDA-MB-231 CEllS
The morphological changes of MDA-MB-231 cells 
were observed after 72 hours of incubation with PTX. 
The unaffected normal viable MDA-MB-231 cells were 
fibroblast-like and were attached to the surface of the 
96-well microplate. However, for the treated cells, they 
exhibited few morphological features characteristic of 
apoptosis such as formation of apoptotic bodies and 
membrane blebbing. There were also cells that became 
smaller and appeared round in shape, a characteristic of 
dying cells. The number of cells in the treated group was 
obviously lesser than the control. The morphological 
change of MDA-MB-231 cells treated with PTX is shown 
in Figure 6.
The morphological changes of MDA-MB-231 cells 
were observed after 72 hours of incubation with CNE and 
CNA. The unaffected normal viable MDA-MB-231 cells 
were fibroblast-like and were attached to the surface of the 
96-well microplate. For the treated cells, they also exhibited 
fibroblast-like cells and were attached to the surface of 
the 96-well microplate same as the normal viable cells. 
But the number of the cell slightly reduced and appeared 
round in shape. The morphological features characteristic 
of apoptosis such as formation of apoptotic bodies and 
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FIgurE 4. Enhancement of the PTX-induced cell death by high concentration of 100% ethanol extract of C. nutans. Histogram 
showed the percentage of viability with the indicated treatments. The MDA-MB-231 cells were kept in control condition, or treated 
with IC50 of PTX (0.028 µg/ml) alone, or with the 100% ethanol extract of C. nutans alone, or with the 100% ethanol extract of 
C. nutans in combination with IC50 of PTX (0.028 µg/ml) for 72 hours. The data are expressed as mean ± SEM for triplicate from 
three different experiments (n = 3). * Significant difference of cell viability when comparing the C. nutans extract treatment alone 
versus the combination of C. nutans extract plus PTX (p < 0.05). # Significant difference of cell viability when comparing the PTX 
treatment alone versus the combination of C. nutans extract plus PTX (p < 0.05). 
FIgurE 5. Enhancement of the PTX-induced cell death by high concentration of water extract of C. nutans. Histogram showed the 
percentage of viability with the indicated treatments. The MDA-MB-231 cells were kept in control condition, or treated with IC50 
of PTX (0.028 µg/ml) alone, or with the water extract of C. nutans alone, or with the water extract of C. nutans in combination with 
IC50 of PTX (0.028 µg/ml) for 72 hours. The data are expressed as mean ± SEM for triplicate from three different experiments  
(n = 3). * Significant difference of cell viability when comparing the C. nutans extract treatment alone versus the combination of 
C. nutans extract plus PTX (p < 0.05). # Significant difference of cell viability when comparing the PTX treatment alone versus the 
combination of C. nutans extract plus PTX (p < 0.05). 
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membrane blebbing were not observed. The necrotic cells 
were also not observed. The number of cells in the treated 
group was lower than the control. The morphological 
change of MDA-MB-231 cells treated with CNE and CNA 
is shown in Figure 7.
The morphological changes of MDA-MB-231 cells 
were observed after 72 hours of incubation with CNE 
and CNA in combination with PTX (0.028 µg/ml).  The 
unaffected normal viable MDA-MB-231 cells were 
fibroblast-like and were attached to the surface of the 96-
well microplate. For the treated cells, they exhibited the 
morphological features characteristic of apoptosis such 
as membrane blebbing and the cells that became smaller 
and appeared round in shape. The necrotic cells were not 
observed. The number of cells in the treated group was 
lower than the control. The morphological change of MDA-
MB-231 cells treated with CNE and CNA in combination 
with PTX is shown in Figure 8.
FIgurE 6. Effect of PTX on morphology of MDA-MB-231 cells for 72 hours. A: The normal viable cell with the fibroblast-like 
shape and was attached to the surface of 96-well microplate. B: A membrane-bound, apoptotic body that was separated from 
mother cell. C: Blebbing of the cell. D: Cell shrinkage and appeared round in shape. These cells were observed under inverted light 
microscope (20X magnification).
FIgurE 7. Effect 100% ethanol and water extracts of C. nutans extracts on morphology of MDA-MB-231 cells for 72 hours were 
determined under an inverted light microscope. A: The normal viable cell with the fibroblast-like shape and was attached to the 
surface of 96-well microplate. B: Cell shrinkage and appeared round in shape. These cells were observed under inverted light 
microscope (20X magnification). Images 1: Cells treated with 100% ethanol extract of C. nutans. Image 2: Cells treated with water 
extract of C. nutans.
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DISCuSSION
In Malaysia, the leaf extracts of C. nutans are broadly 
used on cancer patients and local practice claims a cure to 
cancer (Fong 2015; Farooqui et al. 2015). Various studies 
had been done to determine the phytochemical compounds 
present in C. nutans. Ethanol, methanol and water are polar 
solvents which usually extract more polar or hydrophilic 
phenolic compounds and flavonoid (Fong 2015). A study 
by Chelyn et al. (2014) had identified four known flavones 
C-glycosides such as shaftoside, orientin, isovitexin and 
vitexin from the ethanolic extract of C. nutans leaves. In 
another study done on ethanol extract of C. nutans, sulfur-
containing compounds were isolated named clinamides 
A-C and 2-cis-entadamide A (Tu et al. 2014).
Phenolic compounds have displayed health-promoting 
benefits and nowadays, they become main concern 
because of their important biological and pharmalogical 
properties, particularly the anti-inflammatory, antioxidant, 
antimutagenic and anticarcinogenic activities (Stalikas 
2007). There is also an example of flavonoid compound 
that has anti-cancer potential which is vitexin that can be 
found in C. nutans. Vitexin-induced antitumor effect and 
cytotoxic activity is exerted via proapoptotic process, 
where it is mediated by a reduced of Bcl-2/Bax ratio and 
caspases activation. Vitexin also has been shown to induce 
apoptotic actions on human breast cancer cell lines and 
have anti-inflammatory activities (Aslam et al. 2015). In 
this study, the cytotoxicity potency of 100% ethanol and 
water extracts of C. nutans alone on MDA-MB-231 cells 
was determined. The 100% ethanol extract showed little 
cytotoxic activity, meanwhile water extract of C. nutans 
did not show any cytotoxic activity against MDA-MB-
231 cells.
Previous study by Fong (2015) also demonstrated that 
water and ethanol extract of C. nutans did not show any 
cytotoxic effect on MCF-7 cells at 72 hours. However, a 
study done by yong et al. (2013) showed that water extract 
of C. nutans had significant inhibition cell proliferation 
in Hela and K-562 cells. The different in activity of 
water extract between the studies might be contributed 
by the type of the cells used where every cell line has 
their own unique characteristics and susceptibility toward 
any treatment. water extract did not show any cytotoxic 
effect against breast cancer cell lines (MCF-7 and MDA-
MB-231) but showed cytotoxic effect on Hela and K-562 
leukemia cells.
we observed the discrepancies in cytotoxic activity 
of 100% ethanol and water extracts of C. nutans on 
MDA-MB-231 cells. Even though both ethanol and water 
are polar solvents which usually extract more polar or 
hydrophilic phenolic compounds and flavonoid, they may 
extract the same compounds from the same plant, but the 
level or amount of each compound extracted might be 
different for each solvent. This also suggests that every 
extract may yield a unique set of compounds (Fong 2015). 
FIgurE 8. Effect of 100% ethanol and water extract of C. nutans in combination with PTX on morphology of MDA-MB-231 cells 
for 72 hours. A: The normal viable cell with the fibroblast-like shape and was attached to the surface of 96-well microplate. B: 
Blebbing of cells. C: Cell shrinkage and appeared round in shape. These cells were observed under inverted light microscope (20X 
magnification). Image 1: The cells treated with 100% ethanol extract of C. nutans in combination with PTX. Image 2: The cells 
treated with water extract of C. nutans in combination with PTX. 
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And this unique set of compounds may have different 
effects on the cells. In this study, we suggest that ethanol 
is a better solvent in extracting cytotoxic agent out of C. 
nutans. 
In this study, the cytotoxicity potency of C. nutans 
extracts in combination with PTX was also determined. 
The 100% ethanol extract of C. nutans enhanced PTX-
induced cell death significantly when combined together, 
meanwhile the water extract of C. nutans inhibited PTX-
induced cell death significantly at highest concentration. It 
is interesting to note that there were contradictions found 
in the results between the treatment with extract alone 
and combination of extract with PTX. For example, 100% 
ethanol extract of C. nutans had only little cytotoxic effect 
when it was used alone against MDA-MB-231 cells but 
significantly enhanced PTX-induced cytotoxicity when 
combined together. For water extract, it did not exhibit 
cytotoxic activity when it was used alone and inhibited 
PTX-induced cytotoxocity significantly at the highest 
concentration when in combination with PTX.
The extract used in this study was crude extract that 
consisted of various substances which have not yet been 
purified and fully characterized. Hence, it is possible for 
substances with antagonistic or synergistic effects can 
be found within the same extract (Elias et al. 2013; Fong 
2015). This may suggest that the compounds contained in 
the crude extract may possess opposing effects when they 
were used alone but exhibited synergistic effects when 
combined with another compounds even though the same 
extract was used. It is also possible for the crude extract to 
have compounds that inhibited another compound when 
combined together even though it did not exhibit any effect 
when it was used alone.
The significant decreased of the cell viability when the 
cells were treated with C. nutans extract in combination 
with PTX compared to C. nutans extract alone may be 
due to the cytotoxic effect of the PTX itself. Based on the 
morphology of the cells treated with combination of C. 
nutans extracts and PTX, the results showed that the cells 
morphology is similar with the cell morphology when 
treated with PTX alone.
Based on the morphology of the cells treated with 
C. nutans extracts alone, the cells exhibited normal cell 
morphology which is fibroblast-like shape, a few cells 
appeared round in shape and number of cells decreased 
compared to control after treated with the extracts. Compare 
to the morphology of the cells treated with PTX, the overall 
cells appeared healthier without significant morphology 
features characteristic of cell death such as apoptotic 
bodies, membrane blebbing or necrosis occurred. 
MDA-MB-231 cell is the type of cell that was used 
in this study. It is a hormone-independent breast cancer 
with aggressive characteristic (Mur et al. 1998; gluz et al. 
2009). This characteristic also may contribute to resistance 
characteristic shown by the cells when treated with the C. 
nutans extracts. Based on the results obtained where CNA 
inhibited the potency of PTX, we suggest that the cancer 
patients under medication of PTX not to consume CNA 
together with PTX. However, further study is needed to 
confirm this finding before conclusion can be made.
CONCluSION
Overall, this finding suggests that CNE was able to increase 
the PTX potency and has potential to be used as new 
combination chemotherapy. However, further study to 
understand the underlying mechanism of the observed PTX 
enhancement by CNE is needed to discover its potential use 
in cancer treatment.
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